Summary
Church & Dwight Co., Inc. (CHD) announced on December 10, 2021, the successful closing of a public offering of $400 million in 2.300% Senior Notes due 2031. The primary purpose of this debt issuance is to finance a portion of the company's recently announced acquisition of the TheraBreath® brand. This strategic move indicates the company's commitment to expanding its product portfolio through significant acquisitions, leveraging debt to fund growth initiatives. Investors should note the key terms of these notes, including their interest rate, maturity date, and redemption provisions. The company retains the option to redeem the notes under specific conditions, including a 'Par Call Date' three months prior to maturity. Importantly, if the TheraBreath acquisition is not completed by April 23, 2022, or if the acquisition agreement is terminated, the company is obligated to redeem these notes. The senior unsecured nature of these notes means they rank equally with other senior unsecured debt but are subordinated to secured debt and all obligations of subsidiaries.
Key Highlights
- 1CHD successfully issued $400 million in 2.300% Senior Notes due 2031.
- 2Proceeds are designated to fund a portion of the acquisition of the TheraBreath® brand.
- 3The notes mature on December 15, 2031, with interest payable semi-annually starting June 15, 2022.
- 4The company has the option to redeem notes, including at par value three months before maturity.
- 5A significant condition for redemption is the potential non-consummation or termination of the TheraBreath Acquisition by April 23, 2022.
- 6The notes are senior unsecured obligations, ranking pari passu with other senior unsecured debt.
- 7The notes are effectively subordinated to secured debt and structurally subordinated to subsidiary obligations.